Market Value15,181,170,000
Total Holdings97
File Date2018-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VYNE / VYNE Therapeutics Inc.
GWP / GW Pharmaceuticals plc
CCXI / ChemoCentryx Inc
US62857M1053 / MyoKardia, Inc.
CERS / Cerus Corporation
ABEO / Abeona Therapeutics Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
CMTA / Clementia Pharmaceuticals Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
SELB / Selecta Biosciences Inc
BLUE / bluebird bio, Inc.
ABUS / Arbutus Biopharma Corporation
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
INSM / Insmed Incorporated
FSTX / F-star Therapeutics Inc
ARWR / Arrowhead Pharmaceuticals, Inc.
TARA / Protara Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc
IDRA / Idera Pharmaceuticals, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
TRIL / Trillium Therapeutics Inc
SGMO / Sangamo Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
ALBO / Albireo Pharma Inc
STML / Stemline Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
MDGN / Medgenics, Inc.
QURE / uniQure N.V.
NBRV / Nabriva Therapeutics Plc
ECYT / Endocyte, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
GHDX / Genomic Health, Inc.
/ Array BioPharma, Inc.
MDWD / MediWound Ltd.
AQST / Aquestive Therapeutics, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
EXEL / Exelixis, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
US64125CAD11 / Neurocrine Bios Bond
220485AB2 / Corsicanto Ii Designated Act Bond
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ONCE / Spark Therapeutics, Inc.
AERI / Aerie Pharmaceuticals Inc
ADMS / Adamas Pharmaceuticals Inc
SAGE / Sage Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
INCY / Incyte Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
LUMO / Lumos Pharma, Inc.
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
RARX / Ra Pharmaceuticals, Inc.
JNCE / Jounce Therapeutics Inc
US74257L1089 / Principia Biopharma Inc.
ACOR / Acorda Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
0HBB / Aimmune Therapeutics Inc
XLRN / Acceleron Pharma Inc
VIRX / Viracta Therapeutics, Inc.
GLYC / GlycoMimetics, Inc.
NTLA / Intellia Therapeutics, Inc.
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
RCUS / Arcus Biosciences, Inc.
BDSI / Biodelivery Sciences International
KRYS / Krystal Biotech, Inc.
TRVN / Trevena, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
GLMD / Galmed Pharmaceuticals Ltd.
SESN / Sesen Bio Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
FTSV / Forty Seven, Inc.
MRUS / Merus N.V.
CFRX / ContraFect Corp
APLS / Apellis Pharmaceuticals, Inc.
INFI / Infinity Pharmaceuticals Inc.
GTHX / G1 Therapeutics, Inc.
XNCR / Xencor, Inc.
TNXP / Tonix Pharmaceuticals Holding Corp.
SGEN / Seagen Inc
VKTX / Viking Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
ALKS / Alkermes plc
ARGX / argenx SE - Depositary Receipt (Common Stock)
DVAX / Dynavax Technologies Corporation
CRNX / Crinetics Pharmaceuticals, Inc.
FLGT / Fulgent Genetics, Inc.
MTEM / Molecular Templates, Inc.
LJPC / La Jolla Pharmaceutical Co.
SYRS / Syros Pharmaceuticals, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
TTOO / T2 Biosystems, Inc.
NVAX / Novavax, Inc.
AFMD / Affimed N.V.
QLGN / Qualigen Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
VNDA / Vanda Pharmaceuticals Inc.
ZYME / Zymeworks Inc.
MGNX / MacroGenics, Inc.
ANAB / AnaptysBio, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
OVID / Ovid Therapeutics Inc.
EYRYY / Erytech Pharma
ARAV / Aravive, Inc.
MRTX / Mirati Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ASMB / Assembly Biosciences, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
NTRA / Natera, Inc.
NVTA / Invitae Corporation
HRTX / Heron Therapeutics, Inc.
IFRX / InflaRx N.V.
ACAD / ACADIA Pharmaceuticals Inc.